Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02361918
Other study ID # CTF-EH0001
Secondary ID
Status Completed
Phase N/A
First received October 26, 2014
Last updated February 8, 2015
Start date March 2012
Est. completion date April 2013

Study information

Verified date February 2015
Source Istanbul University
Contact n/a
Is FDA regulated No
Health authority Turkey: Ministry of Health
Study type Observational

Clinical Trial Summary

Evaluating predictive value of serum procalcitonin, C-Reactive Protein, drain IL-6 and TNF-alpha for anastomotic leakage in post-operative period.


Description:

To search for a biomarker, which might be able to predict rectal anastomotic leakage before its clinical presentation. Serum procalcitonin, C-reactive protein, and drain fluid culture, IL-6 and TNF-α levels were evaluated in 50 consecutive patients with rectal cancer who underwent low anterior resection with colorectal anastomosis.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date April 2013
Est. primary completion date April 2013
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- Patient underwent to colonic resection and had drain

Exclusion Criteria:

- other patients

Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Procedure:
Colon surgery


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Istanbul University

Outcome

Type Measure Description Time frame Safety issue
Primary Predictive values of serum CRP, procalcitonin, drain fluid IL-6 and TNF-alpha levels in anastomotic leakage. 5 day No